Merkel cell carcinoma in a patient with non-Hodgkin's lymphoma: how can metastatic disease be ruled out in the face of systemic manifestations of lymphoproliferative disease?
further research to clarify the role of immunotherapy in MCC and optimize patient selection.Additionally, our analysis revealed no significant difference in survival based on age, indicating that age alone did not independently predict outcomes.This underscores the complex interplay of factors influencing MCC prognosis and highlights the need for comprehensive, individualized patient assessments.
Authors
- Thaís Helena Buffo (ORCID: https://orcid.org/0000-0002-6833-7596)
- Rafael Fantelli Stelini (ORCID: https://orcid.org/0000-0003-0618-1693)
- João Felipe Leite Bonfitto (ORCID: https://orcid.org/0000-0002-8450-0744)
- Renata Ferreira Magalhães (ORCID: https://orcid.org/0000-0001-9170-932X)
- I. Prado Motta
- GOA Barbosa
- Thiago Jessé Kucarz (ORCID: https://orcid.org/0009-0000-7339-3026)
Institutions
- Universidade Estadual de Campinas (UNICAMP) (BR)
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ejcskn.2025.100653
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00